{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:42:26Z","timestamp":1790023346032,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.xphs.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T16:58:20Z","timestamp":1518886700000},"page":"1648-1655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Labrasol\u00ae and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae"],"prefix":"10.1016","volume":"107","author":[{"given":"Joanne","family":"Heade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead B.","family":"Bleiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12248-011-9307-4","article-title":"Absorption enhancers: applications and advances","volume":"14","author":"Aungst","year":"2012","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2005.04.016","article-title":"A\u00a0lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats","volume":"298","author":"Cilek","year":"2005","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.02.012_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejps.2010.01.006","article-title":"Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery","volume":"39","author":"Wang","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2018.02.012_bib5","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"A\u00a0novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib6","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02627733","article-title":"Enteral absorption of water-in-oil-in-water insulin emulsions in rabbits","volume":"10","author":"Shichiri","year":"1974","journal-title":"Diabetologia"},{"key":"10.1016\/j.xphs.2018.02.012_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.012_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xphs.2018.02.012_bib11","first-page":"1","article-title":"Currently marketed oral lipid-based dosage forms: drug products and excipients","volume":"Vol. 170","author":"Robert","year":"2007"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.02.012_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2017.04.038","article-title":"Lipophilic peptide character \u2013 what oral barriers fear the most","volume":"255","author":"Zupan\u010di\u010d","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.012_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.14.15","article-title":"Formulation strategies to improve oral peptide delivery","volume":"3","author":"Maher","year":"2014","journal-title":"Pharm Pat Anal"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib15","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter Phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3-4","key":"10.1016\/j.xphs.2018.02.012_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"Pt B","key":"10.1016\/j.xphs.2018.02.012_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.02.012_bib18","series-title":"Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics","article-title":"Chapter 9, Solubilizing vehicles for oral formulation development","author":"Strickley","year":"2007"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13318-016-0374-x","article-title":"Absorption, distribution, metabolism, and excretion of the androgen receptor inhibitor enzalutamide in rats and dogs","volume":"42","author":"Ohtsu","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.012_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10611860290022688","article-title":"Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats","volume":"10","author":"Eaimtrakarn","year":"2002","journal-title":"J\u00a0Drug Target"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.02.012_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2005.11.009","article-title":"Gastro-intestinal patch system for the delivery of erythropoietin","volume":"111","author":"Venkatesan","year":"2006","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.06.018","article-title":"The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats","volume":"379","author":"Hamid","year":"2009","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2018.02.012_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4155\/tde.11.132","article-title":"Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET)","volume":"2","author":"Walsh","year":"2011","journal-title":"Ther Deliv"},{"issue":"15","key":"10.1016\/j.xphs.2018.02.012_bib24","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2017.14752","article-title":"Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with Type 2 diabetes: a randomized clinical trial","volume":"318","author":"Davies","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-016-9996-9","article-title":"Development of a non-aqueous dispersion to improve intestinal epithelial flux of poorly permeable macromolecules","volume":"19","author":"Maher","year":"2017","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0378-5173(79)90053-X","article-title":"Improvement of absolute bioavailability of normally poorly absorbed drugs: inducement of the intestinal absorption of streptomycin and gentamycin by lipid-bile salt mixed micelles in rat and rabbit","volume":"2","author":"Muranishi","year":"1979","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.02.012_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejps.2016.10.006","article-title":"Prediction of drug intestinal absorption in human using the Ussing chamber system: a comparison of intestinal tissues from animals and humans","volume":"96","author":"Miyake","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.012_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1018909210879","article-title":"Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route","volume":"10","author":"Anderberg","year":"1993","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2018.02.012_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejps.2012.08.010","article-title":"Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers","volume":"47","author":"Petersen","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib32","doi-asserted-by":"crossref","first-page":"G800","DOI":"10.1152\/ajpgi.00170.2009","article-title":"Glucagon-like peptide-2 modulates neurally-evoked mucosal chloride secretion in Guinea pig small intestine in\u00a0vitro","volume":"297","author":"Baldassano","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.xphs.2018.02.012_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sj\u00f6berg","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.02.012_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s004240100574","article-title":"Fatty acids inhibit anion secretion in rat colon: apical and basolateral action sites","volume":"442","author":"Schultheiss","year":"2001","journal-title":"Pflugers Arch"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.02.012_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.08.008","article-title":"Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs","volume":"268","author":"Rama Prasad","year":"2003","journal-title":"Int J Pharm"},{"issue":"15","key":"10.1016\/j.xphs.2018.02.012_bib36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in\u00a0vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.02.012_bib37","doi-asserted-by":"crossref","unstructured":"Tadros TF. Industrial applications of surfactants. In: An Introduction to Surfactants. Chapter 11. Berlin, Germany: De Gruyter; 2014:179-220.","DOI":"10.1515\/9783110312133.179"},{"key":"10.1016\/j.xphs.2018.02.012_bib38","doi-asserted-by":"crossref","unstructured":"Hargreaves AE. Surfactants in action. In: Chemical Formulation\u2013An Overview of Surfactant-Based Preparations Used in Everyday Life. Chapter 2. London, UK:Royal Society of Chemistry; 2003:48-88.","DOI":"10.1039\/9781847550385-00048"},{"issue":"7","key":"10.1016\/j.xphs.2018.02.012_bib40","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/mp500776a","article-title":"Interaction with mixed micelles in the intestine attenuates the permeation enhancing potential of alkyl-maltosides","volume":"12","author":"Gradauer","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.012_bib41","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s11095-008-9542-2","article-title":"Mechanistic analysis of chemical permeation enhancers for oral drug delivery","volume":"25","author":"Whitehead","year":"2008","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1208\/s12249-013-0065-8","article-title":"A\u00a0prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug","volume":"15","author":"Alvi","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.02.012_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2018.01.008","article-title":"Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae","volume":"539","author":"Maher","year":"2018","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib44","doi-asserted-by":"crossref","first-page":"e1176822","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: a mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.24603","article-title":"Characterization of human duodenal fluids in fasted and fed state conditions","volume":"105","author":"Riethorst","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5713\/ajas.14.0328","article-title":"Effects of dietary coconut oil as a medium-chain fatty acid source on performance, carcass composition and serum lipids in male broilers","volume":"28","author":"Wang","year":"2015","journal-title":"Asian-Australas J Anim Sci"},{"key":"10.1016\/j.xphs.2018.02.012_bib47","first-page":"9","article-title":"Predicting drug absorption and the effects of food on oral bioavailability","volume":"99","author":"Benet","year":"2006","journal-title":"Bull Techn Gattefosse"},{"issue":"6","key":"10.1016\/j.xphs.2018.02.012_bib48","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s11095-007-9236-1","article-title":"Predicting effect of food on extent of drug absorption based on physicochemical properties","volume":"24","author":"Gu","year":"2007","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2018.02.012_bib49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbalip.2007.02.009","article-title":"Comparative study on digestive lipase activities on the self-emulsifying excipient Labrasol, medium chain glycerides and PEG esters","volume":"1771","author":"Fernandez","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xphs.2018.02.012_bib50","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s11095-009-9906-2","article-title":"In\u00a0vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self-emulsifying excipients Labrasol and Gelucire 44\/14","volume":"26","author":"Fernandez","year":"2009","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2018.02.012_bib51","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1021\/mp500197b","article-title":"An in\u00a0vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in danazol bioavailability from lipid based formulations","volume":"11","author":"Anby","year":"2014","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.02.012_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s13346-017-0383-6","article-title":"Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems","volume":"8","author":"Sadhukha","year":"2018","journal-title":"Drug Deliv Transl Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918300960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918300960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:41:47Z","timestamp":1660484507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918300960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022354918300960"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.02.012","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Labrasol\u00ae and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}